Skip to content

VRTX

Vertex Pharmaceuticals Incorporated

Revenue to net income

Key figures

MetricLast 12 months5-year CAGR
Revenue$13.0B+14.1%
Gross profit$11.1B+13.6%
Operating income$4.3B+7.9%
Net income$4.0B+7.8%
EPS$15.54+8.3%
Free cash flow$3.2B+1.3%